Study design and endpoints in graft-versus-host disease
- 30 June 2008
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Haematology
- Vol. 21 (2), 357-372
- https://doi.org/10.1016/j.beha.2008.03.001
Abstract
The design of clinical trials for prevention or treatment of acute or chronic graft-versus-host disease poses many challenges. These challenges include the selection of primary and secondary endpoints that demonstrate clinical benefit, and the identification of measures indicating success both for individual patients and groups. Assessment of response in treatment trials should ideally encompass the prior trajectory of change before treatment. The criteria, timing and duration of response should be specified, and the potential effects of concomitant treatment and complications other than GVHD should be taken into account in assessing outcomes. A crucial element in clinical trial design is the pre-specification of the hypothesis to be tested in quantitative terms. Potential barriers to enrollment should be carefully considered in order to ensure timely completion of the trial.Keywords
This publication has 22 references indexed in Scilit:
- Murine Models of Chronic Graft-versus-Host Disease: Insights and Unresolved IssuesTransplantation and Cellular Therapy, 2008
- Graft-versus-host diseaseNature Reviews Immunology, 2007
- Immunobiology of Allogeneic Hematopoietic Stem Cell TransplantationAnnual Review of Immunology, 2007
- Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group ReportTransplantation and Cellular Therapy, 2006
- Toward Biomarkers for Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. Biomarker Working Group ReportTransplantation and Cellular Therapy, 2006
- Pathophysiology of Graft-Versus-Host DiseaseSeminars in Hematology, 2006
- Histopathologic Diagnosis of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group ReportTransplantation and Cellular Therapy, 2006
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group ReportTransplantation and Cellular Therapy, 2005
- Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantationHepatology, 2005
- Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantationTransplantation and Cellular Therapy, 2004